CTLA-4 is a crucial checkpoint in the cancer immunity cycle, and blocking it enhances T cell activation.72 The model divides cells into four compartments: irradiated tumor cells, dying tumor cells, non-irradiated tumor cells, and circulating lymphocytes. The gene discussed is CTLA4; the disease is neoplasm.